跳至主要内容
临床试验/NL-OMON51653
NL-OMON51653招募中不适用

Reduction of complications for head and neck cancer: Individual lymph node irradiation (iNode) - iNode

niversitair Medisch Centrum Utrecht0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Squamous cell carcinoma of the larynx, oropharynx or hypopharynx
  • - T2 -T4 stage
  • - N0-1, based on bilateral ultrasound / MRI / PET of the neck
  • - Indication for curative primary (accelerated) RT
  • - Indication for bilateral ENI

排除标准

  • - Concurrent chemotherapy or cetuximab
  • - Patients unsuited for MRI imaging
  • - Synchronous malignant tumor(s) at another site
  • - Previous malignancies in the HN region treated with surgery, chemotherapy or
  • radiotherapy, except for tumors treated with endoscopic glottic laser
  • microsurgery.
  • - Previous dissection of LNs in the neck
  • - A history of malignant disease for which treatment was ended < 2 year before
  • diagnosis of the HNSCC, except basal cell carcinoma
  • - Age <18 years
  • - WHO performance status: >= 2
  • - Distant metastasis
  • - Participation into another interventional study
  • - Mental or physical impairment causing the participant to be unable to fill
  • out questionnaires

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验